Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

0.6711
Delayed Data
As of Jan 22
 -0.0163 / -2.37%
Today’s Change
0.60
Today|||52-Week Range
4.95
-12.84%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close0.69
Today’s open0.68
Day’s range0.65 - 0.69
Volume152,781
Average volume (3 months)235,167
Market cap$23.5M
Data as of 4:00pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+39.68%
Earnings growth (this year)-6.41%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
CLBSCaladrius Bioscience...+0.12+2.92%
ALPNAlpine Immune Scienc...+0.66+6.07%
MTEMMolecular Templates ...+0.12+1.01%
CSBRChampions Oncology I...-0.08-2.02%
Data as of 4:00pm ET, 01/22/2018

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$23.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Medical Officer
Richard Toselli
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts